Israeli Medical Cannabis Strains Win at Canadian Cannabis Awards

December 10, 2017 | Cannabis strains from Tikun Olam, an Israeli brand recognized as the pioneer of modern medical cannabis for the past 10 years, took first place in three categories at the 2017 Canadian Cannabis Awards. The Eran Almog strain took first place for  Top High THC Flower. The Avidekel strain took first place for Top High CBD Flower and Top High CDB Oil. The Midnight strain took second place in Top Hybrid Flower. These strains are grown, processed, and distributed in Canada through a licensing agreement with MedReleaf, a company that was named Top Licensed Producer at the awards this year. Since 2010, Tikkun Olam products have been used in ongoing clinical trials in Israel’s regulated medical cannabis market. They have treated sufferers of medical conditions such as cancer, PTSD, AIDS, cerebral palsy, chronic pain and more. U.S. operations for Tikkun Olam were established in 2015 as T.O. global in a joint venture with Tikun Olam in Israel. There are similar partnerships in Canada, Australia, UK, and South Africa. Tikkun Olam’s mission is to educate the traditional medical community and its patients on the application of cannabis as a scientifically proven wellness product.